Gilead Prices $3.5 Billion of Senior Unsecured Notes
(Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, today announced the pricing of senior unsecured notes in an aggregate ...
Yahoo15h
10 facts you never knew about the Transgender Pride Flag
We have officially kicked off Transgender Awareness Week — which is about to turn into just “Transgender Awareness” come 2025 ...
Gilead reports positive HIV PrEP data for lenacapavir
Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...
Dystopian Novels See Boost in Sales After Election, From ‘Handmaid’s Tale’ to ‘1984’
Millions of Americans who were hoping for a different result from the presidential election have coped with the news in ...
Why Gilead's Solid Q3 Earnings Could Point To A Dividend Surprise Next Year
Gilead Sciences' Q3 2024 results exceeded expectations, driven by a strong performance of the HIV portfolio. Read why I ...